<SEC-DOCUMENT>0001193125-26-257379.txt : 20260604
<SEC-HEADER>0001193125-26-257379.hdr.sgml : 20260604
<ACCEPTANCE-DATETIME>20260604160519
ACCESSION NUMBER:		0001193125-26-257379
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260603
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260604
DATE AS OF CHANGE:		20260604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Minerva Neurosciences, Inc.
		CENTRAL INDEX KEY:			0001598646
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				260784194
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36517
		FILM NUMBER:		261064893

	BUSINESS ADDRESS:	
		STREET 1:		1500 DISTRICT AVENUE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803
		BUSINESS PHONE:		617-600-7373

	MAIL ADDRESS:	
		STREET 1:		1500 DISTRICT AVENUE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d57321d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nerv="http://minervaneurosciences.com/20260603" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2026-06-03_to_2026-06-03">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-628">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-06-03_to_2026-06-03">0001598646</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2026-06-03_to_2026-06-03" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2026-06-03_to_2026-06-03">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="nerv-20260603.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-06-03_to_2026-06-03"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001598646</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-06-03</xbrli:startDate> <xbrli:endDate>2026-06-03</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-640">8-K</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt:datemonthdayyearen" id="ixv-641">June&#160;3, 2026</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-642">Minerva Neurosciences, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:stateprovnameen" id="ixv-643">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-644">001-36517</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-645">26-0784194</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-646">1500 District Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-647">Burlington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-648">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-649">01803</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices (Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-650">(617)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-651">600-7373</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:boolballotbox" id="ixv-652">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:boolballotbox" id="ixv-653">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:boolballotbox" id="ixv-654">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each executive<br/>on which registration</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-655">Common Stock, $0.0001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-656">NERV</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#8194;<ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:boolballotbox" id="ixv-657"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-06-03_to_2026-06-03" format="ixt-sec:boolballotbox" id="ixv-658">&#9744;</ix:nonNumeric></ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;3.03</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth under Item 5.03 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference into this Item 3.03. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.03</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Minerva Neurosciences, Inc. (the &#8220;Company&#8221;) held its 2026 Annual Meeting of Stockholders (the &#8220;2026 Annual Meeting&#8221;) on June&#160;3, 2026. At the 2026 Annual Meeting, the Company&#8217;s stockholders approved amendments to the Company&#8217;s Amended and Restated Certificate of Incorporation (as amended, the &#8220;Existing Charter&#8221;) to: (i)&#160;limit the liability of certain officers for monetary damages to the fullest extent permitted by Delaware law (the &#8220;Exculpation Amendment&#8221;) and (ii)&#160;to eliminate the exclusive forum provision (the &#8220;Exclusive Forum Amendment&#8221;). The Exculpation Amendment and the Exclusive Forum Amendment are described in detail under &#8220;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001598646/000119312526171799/d113727ddef14a.htm#toc113727_16">Proposal 2: Approval of an Amendment to Our Amended and Restated Certificate of Incorporation to Reflect Delaware Law Provisions Allowing for the Exculpation of Certain Officers</a>&#8221; and &#8220;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001598646/000119312526171799/d113727ddef14a.htm#toc113727_17">Proposal 3: Approval of an Amendment to Our Amended and Restated Certificate of Incorporation to Eliminate the Exclusive Forum Provision</a>,&#8221; respectively, of the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on April&#160;23, 2026 (the &#8220;2026 Proxy Statement&#8221;), which descriptions are incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Exculpation Amendment and the Exclusive Forum Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Existing Charter, as amended by such amendments (the &#8220;Restated Charter&#8221;), a copy of which is filed as Exhibit 3.1 to this Current Report and incorporated herein by reference. The Restated Charter became effective upon its filing with the Secretary of State of the State of Delaware on June&#160;4, 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, on June&#160;3, 2026, the Board of Directors (the &#8220;Board&#8221;) of the Company approved an amendment and restatement of the Company&#8217;s bylaws (as so amended and restated, the &#8220;Amended and Restated Bylaws&#8221;), effective immediately. The amendments effected by the Amended and Restated Bylaws, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">update the provisions governing postponement, rescheduling and cancellation of annual and special stockholder meetings to specifically vest that authority in the Board, or any director or officer to whom the Board delegates such authority, at any time before or after notice of such meeting is given to stockholders, and clarify that notice of an adjourned meeting need not be separately given if the adjournment information is displayed on the electronic network used for the meeting during the time scheduled for the meeting, or is set forth in the original notice of meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">update the advance notice provision including, without limitation, to: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">clarify that a nominating stockholder shall be a stockholder of record at the time of the annual meeting in addition to at the time of giving notice; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">eliminate the prior <span style="white-space:nowrap">carve-out</span> acknowledging nominations and proposals properly brought pursuant to applicable provisions of federal law, including the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the rules and regulations of the Securities and Exchange Commission thereunder, as an alternative basis for compliance with the advance notice procedures; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">update the notice deadline applicable when the annual meeting date falls outside the window tied to the anniversary of the prior year&#8217;s annual meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">clarify that the election of directors shall not be a proper subject for stockholder action at a meeting that is called by stockholders, if at such time the stockholders are prohibited from filling vacancies or newly created directorships on the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limit the number of nominees that a stockholder may nominate for election at a meeting to the number of directors to be elected at such meeting; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reflect the universal proxy rules as set forth in Rule <span style="white-space:nowrap">14a-19</span> under the Exchange Act by, among other things, (i)&#160;requiring additional background information and disclosures regarding proposing stockholders and proposed nominees, (ii)&#160;requiring the stockholder making a nomination to represent whether it will comply with the universal proxy rules and (iii)&#160;providing that the nomination will be disregarded if the stockholder does not comply with the universal proxy rules; </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">address adjournment of stockholder meetings relying on remote communication due to a technical failure; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">eliminate the former requirement that the list of stockholders entitled to vote at a stockholder meeting also be made available during the actual meeting; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">amend the manner of acting to provide that where a different or minimum vote is provided by law or by applicable stock exchange rules, or by the certificate of incorporation or the bylaws of the Company, such different or minimum vote shall be the applicable vote on the matter; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">amend exclusive forum provisions to add any appellate court from the Court of Chancery as part of the designated forum for certain derivative and state law claims and designate the United States District Court for the District of Delaware as a fallback forum if the Court of Chancery lacks or declines jurisdiction; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">designate the federal district courts of the United States of America as the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Bylaws also include various other updates, including certain technical, conforming and clarifying changes. The foregoing description of the Amended and Restated Bylaws is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, a copy of which is filed as Exhibit&#160;3.2 hereto and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.07</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company held its 2026 Annual Meeting on June&#160;3, 2026. As of April&#160;9, 2026, the record date for the 2026 Annual Meeting, 43,841,998 shares of common stock of the Company were issued and outstanding. In addition, 3,296 shares of Series A Convertible Voting Preferred Stock were issued and outstanding, of which 196 shares have voting rights after taking into account the Maximum Percentage as described in the 2026 Proxy Statement, resulting in 92,708 shares of common stock on an <span style="white-space:nowrap">as-converted</span> to common stock basis. Therefore, there are 43,934,706 shares of common stock entitled to vote as of the record date. Each share of common stock is entitled to one vote. Each share of Series A Convertible Voting Preferred Stock outstanding as of the record date has the right to vote on an <span style="white-space:nowrap">as-converted</span> to common stock basis (i.e., each share of Series A Convertible Voting Preferred Stock is convertible into 473 shares of common stock), together with the shares of common stock and voting together as a single class, on all matters presented to the stockholders for approval, subject to the Maximum Percentage (as defined in the 2026 Proxy Statement). The final results for each of the proposals submitted to a vote of the Company&#8217;s stockholders at the 2026 Annual Meeting are set forth below. These proposals are described in the 2026 Proxy Statement: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 1: Election of Directors</span></span>. Two nominees were elected to serve on the Board until the Company&#8217;s 2029 annual meeting of stockholders and until their successors are elected and qualified. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:63%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Nominee</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2"><span style="font-weight:bold">Withheld</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2"><span style="font-weight:bold"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&#160;David Kupfer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">23,211,099</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,182,190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,904,233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jan van Heek</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,369,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">23,956</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,904,233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 2: Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Reflect Delaware Law Provisions Allowing for the Exculpation of Certain Officers</span></span>. The Company&#8217;s stockholders approved Proposal 2. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Broker <span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom;text-align:center">27,222,961</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">3,169,756</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">572</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">4,904,233</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 3: Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Eliminate the Exclusive Forum Provision</span></span>. The Company&#8217;s stockholders approved Proposal 3. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Broker <span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top;text-align:center">30,360,809</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">20,954</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">11,526</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">4,904,233</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 4: Approval, on an Advisory Basis, of the Compensation of the Company&#8217;s Named Executive Officers, as disclosed in the Proxy Statement</span></span>. The Company&#8217;s stockholders approved Proposal 4. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Broker <span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top;text-align:center">27,183,828</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">3,196,678</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">12,783</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">4,904,233</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 5: Approval, on an Advisory Basis, of the Frequency of Solicitation of Future Advisory Stockholder Approval of Named Executive Officer Compensation</span></span>. The Company&#8217;s stockholders approved Proposal 5. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:18%"/>

<td style="vertical-align:bottom"/>
<td style="width:19%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:20%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:19%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">1 Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">2 Years</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">3 Years</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Broker <span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top;text-align:center">30,365,516</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">1,639</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">9,934</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">16,200</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center">4,904,233</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s stockholders voted one year for the frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers. Consistent with these results, the Board determined that future stockholder advisory votes on named executive officer compensation will be held every year until the next required advisory vote on the frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Proposal 6: Ratification of Deloitte</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;&amp; Touche LLP as the independent registered public accounting firm for the Company&#8217;s fiscal year ending December</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;31, 2026</span></span>. The selection of Deloitte&#160;&amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2026 was ratified. The voting results were as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Broker <span style="white-space:nowrap">Non-Votes</span></span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom;text-align:center">35,289,299</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">7,131</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">1,092</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">&#8212;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) &#8195;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d57321dex31.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Minerva Neurosciences, Inc., effective June&#160;4, 2026 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d57321dex32.htm">Amended and Restated Bylaws of Minerva Neurosciences, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">MINERVA NEUROSCIENCES, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;4, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Frederick Ahlholm</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Frederick Ahlholm</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d57321dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MINERVA NEUROSCIENCES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Minerva Neurosciences, Inc. (the &#8220;<B><I>Corporation</I></B>&#8221;), a corporation organized and existing under and by virtue of the
General Corporation Law of the State of Delaware (the &#8220;<B><I>DGCL</I></B>&#8221;), does hereby certify that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F<SMALL>IRST</SMALL>:</B> The name of the Corporation is Minerva Neurosciences, Inc. The Certificate of Incorporation of the Corporation was
originally filed with the Secretary of State of the State of Delaware on April&nbsp;23, 2007 under the original name of the Corporation, Cyrenaic Pharmaceuticals, Inc., and was corrected by a Certificate of Correction filed with the Secretary of
State of the State of Delaware on May&nbsp;16, 2007. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on August&nbsp;29, 2007 and was amended by the Certificate of Merger filed with
the Secretary of State of the State of Delaware on November&nbsp;12, 2013. A second Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on June&nbsp;9, 2014 and was further amended by a
Certificate of Amendment filed with the Secretary of State of the State of Delaware on June&nbsp;17, 2022 and a second Certificate of Amendment filed with the Secretary of State of the State of Delaware on December&nbsp;22, 2025 (the
&#8220;<B><I>Certificate of Incorporation</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>ECOND</SMALL>:</B> The Board of Directors of the Corporation (the
&#8220;<B><I>Board</I></B>&#8221;), acting in accordance with the provisions of Sections 141 and 242 of the DGCL, adopted resolutions amending the Certificate of Incorporation, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RESOLVED, that Article EIGHTH, paragraph (a), shall be amended and restated to read in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;(a) No director or officer of the Corporation shall be liable to the Corporation or its stockholders for monetary damages for breach of
fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted under the GCL, as the same exists or may hereafter be amended. Any amendment, modification or repeal of the foregoing
sentence shall not adversely affect any right or protection of a director or officer of the Corporation hereunder in respect of any act or omission occurring prior to the time of such amendment, modification or repeal. Solely for purposes of this
Article EIGHTH, paragraph (a), &#8220;officer&#8221; shall have the meaning provided in Section&nbsp;102(b)(7) of the GCL.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RESOLVED FURTHER, that Article NINTH shall be amended and restated to read in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>NINTH</U>: [Reserved.]&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIRD</SMALL>:</B> The foregoing amendment to the Certificate of Incorporation was duly approved by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F<SMALL>OURTH</SMALL></B><SMALL></SMALL>: Thereafter, pursuant to a resolution of the Board, this Certificate of Amendment was submitted to
the stockholders of the Corporation for their approval, and was duly adopted in accordance with the provisions of Section&nbsp;242 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL>,</B> the undersigned has
caused this Certificate of Amendment to be signed by its duly authorized officer on this 4<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of June, 2026. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MINERVA NEUROSCIENCES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Remy Luthringer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Remy Luthringer Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>d57321dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BYLAWS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MINERVA NEUROSCIENCES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(a Delaware Corporation) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Adopted as of June&nbsp;3, 2026 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICES AND
FISCAL YEAR </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.01. </B><B><U>Registered Office</U></B><B>.</B> The registered office of the corporation shall be Corporation Service
Company, 2711 Centerville Road, Suite 400, City of Wilmington, County of New Castle, State of Delaware until otherwise established by resolution of the board of directors, and a certificate certifying the change is filed in the manner provided by
statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.02. </B><B><U>Other Offices</U></B><B>.</B> The corporation may also have offices at such other places within or without the State
of Delaware as the board of directors may from time to time determine or the business of the corporation requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 1.03. </B><B><U>Fiscal
Year</U></B><B>.</B> The fiscal year of the corporation shall end on the 31st of December in each year. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE - WAIVERS &#8211; MEETINGS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.01. </B><B><U>Notice of Meetings of Board of Directors</U></B><B>.</B> Notice of a regular meeting of the board of directors need not be given.
Notice of every special meeting of the board of directors shall be given to each director by telephone or in writing at least 24 hours (in the case of notice by telephone, telex, TWX or facsimile transmission) or 48 hours (in the case of notice by
telegraph, courier service or express mail) or five days (in the case of notice by first class mail) before the time at which the meeting is to be held. Every such notice shall state the time and place of the meeting. Neither the business to be
transacted at, nor the purpose of, any regular or special meeting of the board need be specified in a notice of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.02.
</B><B><U>Notice of Meetings of Stockholders</U></B><B>.</B> Notice of the place, if any, date and time of all meetings of stockholders of the Corporation, and the means of remote communications, if any, by which stockholders and proxy holders may
be deemed present and vote at such meeting, and, in the case of all special meetings of stockholders, the purpose of the meeting, shall be given, not less than 10 nor more than 60 days before the date on which such meeting is to be held, to each
stockholder entitled to notice of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any meeting of stockholders, whether annual or special, may be adjourned from time to time either by the
chairperson of the meeting or by the stockholders by the affirmative vote of a majority of the votes cast, voting affirmatively or negatively (excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes).</FONT> When a meeting is
adjourned to another time or place (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice need not be given of the adjourned meeting if the time and place, if any, thereof
and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken or are (i)&nbsp;displayed, during
the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication or (ii)&nbsp;set forth in the notice of meeting given in accordance with
Section&nbsp;2.03; however, if the date of any adjourned meeting is more than 30 days after the date for which the meeting was originally noticed, or if a new record date is fixed for voting at the adjourned meeting, notice of the place, if any,
date and time of the adjourned meeting and the means of remote communication, if any, by which stockholders and proxy holders may be deemed present and vote at such adjourned meeting, shall be given in conformity herewith. At any adjourned meeting,
any business may be transacted that may have been transacted at the original meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.03. </B><B><U>Method of Notice</U></B><B>. </B>If mailed, notice to a stockholder of the
Corporation shall be deemed given when deposited in the mail, postage prepaid, directed to a stockholder at such stockholder&#8217;s address as it appears on the records of the Corporation. Without limiting the manner by which notice otherwise may
be given effectively to stockholders, any notice to stockholders of the Corporation may be given by electronic transmission in the manner provided in Section&nbsp;232 of the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.04. </B><B><U>Waiver of Notice</U></B><B>. </B>A written waiver of any notice, signed by a stockholder or director, or a waiver by electronic
transmission by such person or entity, whether given before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required to be given to such person or entity. Neither the business nor the purpose
of any meeting need be specified in the waiver. Attendance at any meeting shall constitute waiver of notice except attendance for the sole purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting
is not lawfully called or convened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 2.05. </B><B><U>Conference Telephone Meetings</U></B><B>.</B> One or more directors may participate in a
meeting of the board, or of a committee of the board, by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other. Participation in a meeting pursuant to this
section shall constitute presence in person at such meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.01.
</B><B><U>Place of Meeting</U></B><B>.</B> All meetings of the stockholders of the corporation may be held at such place, if any, either within or without the State of Delaware, as may be determined from time to time by the the board of directors
(or its designee). The board of directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.02. </B><B><U>Annual Meeting</U></B><B>.</B> The board of directors may fix and designate the date and time of the annual meeting of the
stockholders, and at said meeting the stockholders then entitled to vote shall elect directors and shall transact such other business as may properly be brought before the meeting. Any annual meeting of stockholders may be postponed, rescheduled or
cancelled by the board of directors, or any director or officer of the Corporation to whom the board of directors delegates such authority, at any time before or after notice of such meeting has been given to stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.03. <U>Advance Notice of Nominations and Proposals of Business</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Nominations of persons for election to the Board of Directors and proposals for business to be transacted by the stockholders at an annual meeting of
stockholders may be made (i)&nbsp;pursuant to the Corporation&#8217;s notice with respect to such meeting, (ii)&nbsp;by or at the direction of the Board of Directors or (iii)&nbsp;by any stockholder of record of the Corporation who (A)&nbsp;was a
stockholder of record at the time of the giving of the notice contemplated in Section&nbsp;3.03(b) and is a stockholder of record at the time of the annual meeting, (B)&nbsp;is entitled to vote at such meeting and (C)&nbsp;has complied with the
notice procedures set forth in this Section&nbsp;3.03. Except as otherwise required by law, clause (iii)&nbsp;of this Section&nbsp;3.03(a) shall be the exclusive means for a stockholder to make nominations or propose other business before an annual
meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Except as otherwise required by law, for nominations or proposals to be properly brought before an annual meeting by a
stockholder pursuant to clause (iii)&nbsp;of Section&nbsp;3.03(a), (i) the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation with the information contemplated by Section&nbsp;3.03(c), and (ii)&nbsp;the
business must be a proper matter for stockholder action under the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) To be timely for purposes of Section&nbsp;3.03(b), a stockholder&#8217;s
notice must be delivered to the Secretary of the Corporation at the principal executive offices of the Corporation a date (i)&nbsp;not less than 90 nor more than 120 days prior to the anniversary date of the prior year&#8217;s annual meeting or
(ii)&nbsp;if there was no annual meeting in the prior year or if the date of the current year&#8217;s annual meeting is more than 30 days before or more than 70 days after the anniversary date of the prior year&#8217;s annual meeting, not earlier
than the 120th day prior to such annual meeting and not later than the later of the close of business on (i)&nbsp;the 90th day prior to such annual meeting or (ii)&nbsp;the tenth day following the day on which public announcement (as defined below)
of the date of such meeting is first made by the Corporation. In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the delivery of such notice. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(1) For nominations for the election to the board of directors to be properly brought before
an annual meeting by a stockholder pursuant to clause (iii)&nbsp;of Section&nbsp;3.03(a), in addition to all of the information required by Section&nbsp;3.03(c)(3) below, such stockholder&#8217;s notice shall include as to each nominee such
stockholder proposes to nominate at the meeting: (A)&nbsp;the name, age, business address and residence address of such nominee, (B)&nbsp;the principal occupation or employment of such nominee, (C)&nbsp;the class or series and number of shares of
each class or series of capital stock of the Corporation that are owned of record and beneficially by such nominee and list of any pledge of or encumbrances on such shares, (D)&nbsp;the date or dates on which such shares were acquired and the
investment intent of such acquisition, (E)&nbsp;the questionnaire, representation and agreement required by Section&nbsp;3.03(f), completed and signed by such nominee, and (F)&nbsp;all other information concerning such nominee as would be required
to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved and whether or not proxies are being or will be solicited), or that is
otherwise required to be disclosed or provided to the Corporation pursuant to Section&nbsp;14 of the 1934 Act (including such person&#8217;s written consent to being named in a proxy statement, associated proxy card and other filings as a nominee
and to serving as a director if elected). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Corporation may require any proposed nominee to furnish such other information as it may
reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or to serve on any committee or <FONT STYLE="white-space:nowrap">sub-committee</FONT> of the board of directors, in
either case under any applicable stock exchange listing requirements, applicable law or the Policies (as defined below). The number of nominees a stockholder may nominate for election at an annual meeting on its own behalf (or in the case of a
stockholder giving the notice on behalf of a beneficial owner, the number of nominees a stockholder may nominate for election at an annual meeting on behalf of such beneficial owner) shall not exceed the number of directors to be elected at such
annual meeting. A stockholder may not designate any substitute or alternate nominees unless the stockholder provides timely notice of such substitute or alternate nominee(s) in accordance with this Section&nbsp;3.03, in the case of an annual
meeting, or Section&nbsp;3.04, in the case of a special meeting (and such notice contains all of the information, representations, questionnaires and certifications with respect to such substitute or alternate nominee(s) that are required by these
bylaws with respect to nominees for director). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(2) For business other than nominations for the election to the board of directors to be
properly brought before an annual meeting by a stockholder pursuant to clause (iii)&nbsp;of Section&nbsp;3.03(a), in addition to all of the information required by Section&nbsp;3.03(c)(3) below, such stockholder&#8217;s notice shall include as to
each matter such stockholder proposes to bring before the meeting: (A)&nbsp;a brief description of the business desired to be brought before the meeting, (B)&nbsp;the text of the proposal or business (including the text of any resolutions proposed
for consideration and in the event that such business includes a proposal to amend the bylaws, the language of the proposed amendment), (C) the reasons for conducting such business at the meeting, and (D)&nbsp;any material interest (including any
anticipated benefit of such business to any Proponent (as defined below) other than solely as a result of its ownership of the Corporation&#8217;s capital stock, that is material to any Proponent individually, or to the Proponents in the aggregate)
in such business of any Proponent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(3) The written notice required by Sections 3.03(c)(1) or 3.03(c)(2) shall also include, as of the date
of the notice and as to the stockholder giving the notice, the beneficial owner, if any, on whose behalf the nomination or proposal is made and any affiliate who controls (as such term is defined in Rule 405 under the Securities Act of 1933, as
amended (the &#8220;1933 Act&#8221;) either of the foregoing stockholder or beneficial owner, directly or indirectly (each, a &#8220;Proponent&#8221; and collectively, the &#8220;Proponents&#8221;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) the name and address of each Proponent, including, if applicable, such name and address as they appear on the Corporation&#8217;s books and
records; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) the class, series and number of shares of each class or series of the capital stock of the Corporation that are, directly or
indirectly, owned of record or beneficially (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the 1934 Act) by each Proponent (provided, that for purposes of this Section&nbsp;3.03(c)(3), such Proponent shall in all
events be deemed to beneficially own all shares of any class or series of capital stock of the Corporation as to which such Proponent or any of its affiliates or associates has a right to acquire beneficial ownership whether immediately or at any
time in the future); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(C) a description of any agreement, arrangement or understanding (whether oral or in
writing) with respect to such nomination or proposal (and/or the voting of shares of any class or series of capital stock of the Corporation, other than a revocable proxy given in response to a proxy solicitation made to 10 or more persons) between
or among any Proponent and any of its affiliates or associates, and/or any other persons (including their names) including without limitation, any agreements, arrangements or understandings required to be disclosed pursuant to Item 5 or Item 6 of
1934 Act Schedule 13D, regardless of whether the requirement to file a Schedule 13D is applicable; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(D) a representation that the
stockholder is a holder of record of shares of the Corporation at the time of giving notice, will be entitled to vote at the meeting, and that such stockholder (or a qualified representative thereof) intends to appear at the meeting to nominate the
person or persons specified in the notice (with respect to a notice under Section&nbsp;3.03(c)(1)) or to propose the business that is specified in the notice (with respect to a notice under Section&nbsp;3.03(c)(2)); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(E) a representation whether any Proponent or any other participant (as defined in Item 4 of Schedule 14A under the 1934 Act) will engage in a
solicitation with respect to such nomination or proposal and, if so, the name of each participant in such solicitation and the amount of the cost of solicitation that has been and will be borne, directly or indirectly, by each participant in such
solicitation, and a representation as to whether the Proponents intend or are part of a group which intends to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)
deliver, or make available, a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&#8217;s voting shares required to approve or adopt the proposal or elect the nominee, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) otherwise solicit proxies or votes from stockholders in support of such proposal or nomination, and/or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) solicit proxies in support of any proposed nominee in accordance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT>
promulgated under the 1934 Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(F) a description of all Derivative Transactions (as defined below) by each Proponent during the previous <FONT
STYLE="white-space:nowrap">12-month</FONT> period, including the date of the transactions and the class, series and number of securities involved in, and the material economic or voting terms of, such Derivative Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(G) a certification regarding whether each Proponent has complied with all applicable federal, state and other legal requirements in connection
with such Proponent&#8217;s acquisition of shares of capital stock or other securities of the Corporation and/or such Proponent&#8217;s acts or omissions as a stockholder or beneficial owner of the Corporation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(H) any other information relating to each Proponent required to be disclosed in a proxy statement or other filings required to be made in
connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section&nbsp;14 of the 1934 Act and the rules and regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) A stockholder providing the written notice required by Section&nbsp;3.03(c)(1) or (2)&nbsp;shall update and supplement such notice in
writing, if necessary, so that the information (other than the representations required by Section&nbsp;3.03(c)(3)(E)) provided or required to be provided in such notice is true and correct in all material respects as of (i)&nbsp;the record date for
the determination of stockholders entitled to notice of the meeting and (ii)&nbsp;the date that is five Business Days prior to the meeting and, in the event of any adjournment or postponement thereof, five Business Days prior to such adjourned or
postponed meeting; provided, that no such update or supplement shall cure or affect the accuracy (or inaccuracy) of any representations made by any Proponent, any of its affiliates or associates, or a nominee or the validity (or invalidity) of any
nomination or proposal that failed to comply with this Section&nbsp;3.03 or is rendered invalid as a result of any inaccuracy therein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of an update and supplement pursuant to clause (i)&nbsp;of this Section&nbsp;3.03(d), such
update and supplement must be received by the Secretary at the principal executive offices of the Corporation not later than five Business Days after the later of the record date for the determination of stockholders entitled to notice of the
meeting or the public announcement of such record date. In the case of an update and supplement pursuant to clause (ii)&nbsp;of this Section&nbsp;3.03(d), such update and supplement shall be received by the Secretary at the principal executive
offices of the Corporation not later than two Business Days prior to the date for the meeting, and, in the event of any adjournment or postponement thereof, two Business Days prior to such adjourned or postponed meeting (or if there are fewer than
two Business Days between the date for the meeting, or the date of the immediately preceding adjournment or postponement thereof, and the date for the adjourned or postponed meeting, not later than the day prior to such adjourned or postponed
meeting). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in Section&nbsp;3.03(c)<B> </B>to the contrary, in the event that the number of directors to be elected to the
board at an annual meeting is increased and there is no public announcement by the Corporation naming all of the nominees for director or specifying the size of the increased board of directors at least 10 days before the last day a stockholder may
deliver a notice of nomination in accordance with Section&nbsp;3.03(c), a stockholder&#8217;s notice required by this Section&nbsp;3.03 and that complies with the requirements in Section&nbsp;3.03(c)(1) shall also be considered timely, but only with
respect to nominees for the new positions created by such increase, if it shall be received by the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth day following the day on which such
public announcement is first made by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) To be eligible to be a nominee for election or
<FONT STYLE="white-space:nowrap">re-election</FONT> as a director of the Corporation pursuant to a nomination under clause (iii)&nbsp;of Section&nbsp;3.03(a) or Section&nbsp;3.04, each Proponent must deliver (in accordance with the time periods
prescribed for delivery of notice under Sections 3.03(c), 3.03(e) and/or 3.04, as applicable) to the Secretary at the principal executive offices of the Corporation a completed written questionnaire with respect to the background, qualifications,
stock ownership and independence of such proposed nominee (in the form provided by the Secretary within 10 days following a written request therefor by a stockholder of record) and a written representation and agreement (in the form provided by the
Secretary within 10 days following written request therefor by a stockholder of record) that such person: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) is not and will not become a
party to any agreement, arrangement or understanding (whether oral or in writing) with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, will act or vote on
any issue or question that (x)&nbsp;has not been disclosed in the questionnaire or (y)&nbsp;could limit or interfere with such person&#8217;s ability to comply with such person&#8217;s fiduciary duties under applicable law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) is not and will not become a party to any agreement, arrangement or understanding (whether oral or in writing) with any person or entity
other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director of the Corporation or a nominee that has not been disclosed in such questionnaire;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)<B> </B>would be in compliance, if elected as a director of the Corporation (and a statement as to whether such person, if elected,
intends to comply with), all applicable corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation that are publicly disclosed or which were provided by the Secretary with
the written representation and agreement required by this Section&nbsp;3.03(f) (together, the &#8220;Policies&#8221;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if elected
as a director of the Corporation, intends to serve the entire term until the next meeting at which such candidate would face <FONT STYLE="white-space:nowrap">re-election.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything to the contrary in these bylaws, unless otherwise required by applicable law, in the event that any Proponent (i)&nbsp;provides
notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the 1934 Act with respect to one or more proposed nominees and (ii)&nbsp;subsequently fails to (x)&nbsp;comply with the requirements of Rule <FONT
STYLE="white-space:nowrap">14a-19</FONT> promulgated under the 1934 Act (or fails to timely provide reasonable evidence sufficient to satisfy the Corporation that such Proponent has met the requirements of Rule
<FONT STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the 1934 Act in accordance with the next sentence) or (y)&nbsp;inform the Corporation that they no longer plan to solicit proxies in accordance with the requirements of Rule <FONT
STYLE="white-space:nowrap">14a-19</FONT> under the 1934 Act by delivering a written notice to the Secretary at the principal executive offices of the Corporation within two (2)&nbsp;Business Days after the occurrence of such change, then the
nomination of each such proposed nominee shall be disregarded (and such nominee disqualified from standing for election or <FONT STYLE="white-space:nowrap">re-election),</FONT> notwithstanding that the nominee is included (as applicable) as a
nominee in the Corporation&#8217;s proxy statement, notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto) and notwithstanding that proxies or votes in respect of the election of such proposed nominees may
have been received by the Corporation (which proxies and votes shall be disregarded). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any Proponent provides notice pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT>
promulgated under the 1934 Act, such Proponent shall deliver to the Corporation, no later than five (5)&nbsp;Business Days prior to the applicable meeting, reasonable evidence sufficient to demonstrate that it has met the requirements of Rule <FONT
STYLE="white-space:nowrap">14a-19(a)(3)</FONT> promulgated under the 1934 Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary set forth herein, and for the
avoidance of doubt, the nomination of any person whose name is included (as applicable) as a nominee in the Corporation&#8217;s proxy statement, notice of meeting or other proxy materials for any stockholder meeting (or any supplement thereto) as a
result of any notice provided by any Proponent pursuant to Rule <FONT STYLE="white-space:nowrap">14a-19(b)</FONT> promulgated under the 1934 Act with respect to such proposed nominee and whose nomination is not made by or at the direction of the
board of directors or any authorized committee thereof shall not be deemed (for purposes of clause (i)&nbsp;of Section&nbsp;3.03(a) or otherwise) to have been made pursuant to the Corporation&#8217;s notice of meeting (or any supplement thereto) and
any such nominee may only be nominated by a Proponent pursuant to clause (iii)&nbsp;of Section&nbsp;3.03(a) and, in the case of a special meeting of stockholders, pursuant to and to the extent permitted under Section&nbsp;3.04. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A person shall not be eligible for election or <FONT STYLE="white-space:nowrap">re-election</FONT> as a director at an annual meeting unless the person is
nominated in accordance with clause (ii)&nbsp;or (iii) of Section&nbsp;3.03(a) and in accordance with the procedures and requirements set forth in Section&nbsp;3.03(c), Section&nbsp;3.03(e), Section&nbsp;3.03(f) and Section&nbsp;3.03(g), as
applicable. Only such business shall be conducted at any annual meeting of the stockholders of the Corporation as shall have been brought before the meeting in accordance with Section&nbsp;3.03(a) and in accordance with the procedures and
requirements set forth in Section&nbsp;3.03(c) and Section&nbsp;3.03(g), as applicable. Except as otherwise required by applicable law, and subject to the supervision, direction and control of the board of directors, the chairperson of the meeting
shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures and requirements set forth in the Bylaws
(including, without limitation, compliance with Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> promulgated under the 1934 Act) and, if any proposed nomination or business is not in compliance with the Bylaws, or the Proponent does not act in
accordance with the representations required in this Section&nbsp;3.03, to declare that such proposal or nomination shall not be presented for stockholder action at the meeting and shall be disregarded (and such nominee disqualified from standing
for election or <FONT STYLE="white-space:nowrap">re-election),</FONT> or that such business shall not be transacted, notwithstanding that such proposal or nomination is set forth in (as applicable) the Corporation&#8217;s proxy statement, notice of
meeting or other proxy materials and notwithstanding that proxies or votes in respect of such nomination or such business may have been solicited or received. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;3.03, unless otherwise required by applicable law, if the stockholder (or a qualified
representative of the stockholder) does not appear at the annual meeting of stockholders of the Corporation to present a nomination or proposed business, such nomination shall be disregarded (and such nominee disqualified from standing for election
or <FONT STYLE="white-space:nowrap">re-election)</FONT> and such proposed business shall not be transacted, notwithstanding that such nomination or proposed business is set forth in (as applicable) the Corporation&#8217;s proxy statement, notice of
meeting or other proxy materials and notwithstanding that proxies or votes in respect of such vote may have been solicited or received by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) For purposes of Section&nbsp;3.03: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)
&#8220;affiliates&#8221; and &#8220;associates&#8221; shall have the meanings set forth in Rule 405 under the 1933 Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)
&#8220;Business Day&#8221; means any day other than Saturday, Sunday or a day on which banks are closed in New York City, New York; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#8220;close of business&#8221; means 6:00 p.m. local time at the principal executive
offices of the Corporation on any calendar day, whether or not the day is a Business Day; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) &#8220;Derivative Transaction&#8221; means
any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proponent or any of its affiliates or associates, whether record or beneficial: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the Corporation;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) that otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of
securities of the Corporation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(C) the effect or intent of which is to mitigate loss, manage risk or benefit from changes in value or
price with respect to any securities of the Corporation; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(D) that provides the right to vote (other than a revocable proxy given in
response to a proxy solicitation made to 10 or more persons) or increase or decrease the voting power of, such Proponent, or any of its affiliates or associates, directly or indirectly, with respect to any securities of the Corporation, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note, bond,
convertible security, swap, stock appreciation or similar right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment,
settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proponent in the securities of the Corporation held by any general or limited partnership, or any limited liability company, of which such
Proponent is, directly or indirectly, a general partner or managing member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) a &#8220;qualified representative&#8221; of a stockholder
shall mean (A)&nbsp;a duly authorized officer, manager, trustee or partner of such stockholder or (B)&nbsp;a person authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such
stockholder as proxy at the meeting of stockholders, and such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, shall be provided to the Secretary of the Corporation at least five Business Days
prior to the meeting of stockholders; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) &#8220;public announcement&#8221; means disclosure in a press release reported by the Dow
Jones News Service, Associated Press, Business Wire, GlobeNewswire or comparable national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14 or 15(d) of the
Securities Exchange Act of 1934 (as amended from time to time, the &#8220;1934 Act&#8221;) or by such other means reasonably designed to inform the public or security holders in general of such information, including, without limitation, posting on
the Corporation&#8217;s investor relations website. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.04. </B><B><U>Special Meetings</U></B><B>.</B> Special meetings of the stockholders of
the Corporation may be called only in the manner set forth in the certification of incorporation of the Corporation. Any special meeting of stockholders previously scheduled by the board of directors may be postponed, rescheduled or cancelled by the
board, or any director or officer to whom the board has delegated such authority, at any time before or after notice of such meeting has been given to stockholders. Notice of every special meeting of the stockholders of the Corporation shall state
the purpose of such meeting. Except as otherwise required by law, the business conducted at a special meeting of stockholders of the Corporation shall be limited exclusively to the business set forth in the Corporation&#8217;s notice of meeting, and
the individual or group calling such meeting shall have exclusive authority to determine the business included in such notice. Nominations of persons for election to the board of directors of the Corporation and stockholder proposals of other
business shall not be brought before a special meeting of stockholders to be considered by the stockholders unless such special meeting is held in lieu of an annual meeting of stockholders in accordance with Section&nbsp;3.03 of these bylaws, in
which case such special meeting in lieu thereof shall be deemed an annual meeting for purposes of these bylaws and the provisions of Section&nbsp;3.03 of these bylaws shall govern such special meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.05. <U>Quorum, Manner of Acting and Adjournment</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><U>Quorum</U></B><B>. </B>The holders of a majority of the shares entitled to vote, present in person or represented by proxy, shall constitute a
quorum at all meetings of the stockholders except as otherwise provided by the DGCL, by the certificate of incorporation or by these bylaws. If a quorum is not present or represented at any meeting of the stockholders, the stockholders entitled to
vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present or represented. At any such adjourned meeting at
which a quorum is present or represented, the corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the
adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b)
</B><B><U>Manner of Acting</U></B><B>. </B>Directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Unless a different or minimum
vote is provided by law or by applicable stock exchange rules, or by the certificate of incorporation or these bylaws, in which case such different or minimum vote shall be the applicable vote on the matter, in all matters other than the election of
directors, the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote thereon shall be the act of the stockholders. The stockholders present in person or by proxy at a duly organized
meeting can continue to do business until adjournment, notwithstanding withdrawal of enough stockholders to leave less than a quorum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.06.
</B><B><U>Organization</U></B><B>. </B>At every meeting of the stockholders, the chairman of the board, if there be one, or in the case of a vacancy in the office or absence of the chairman of the board, one of the following persons present in the
order stated: the vice chairman, if one has been appointed, the president, the vice presidents in their order of rank or seniority, a chairman designated by the board of directors or a chairman chosen by the stockholders entitled to cast a majority
of the votes which all stockholders present in person or by proxy are entitled to cast, shall act as chairman, and the secretary, or, in the absence of the secretary, an assistant secretary, or in the absence of the secretary and the assistant
secretaries, a person appointed by the chairman, shall act as secretary. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.07. <U>Voting</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><U>General Rule</U></B><B>.</B> Unless otherwise provided in the certificate of incorporation, each stockholder shall be entitled to one vote, in
person or by proxy, for each share of capital stock having voting power held by such stockholder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) <U>Voting and Other Action by Proxy</U>.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(1) </B>A stockholder may execute a writing authorizing another person or persons to act for the stockholder as proxy. Such execution may be
accomplished by the stockholder or the authorized officer, director, employee or agent of the stockholder signing such writing or causing his or her signature to be affixed to such writing by any reasonable means including, but not limited to, by
facsimile signature. A stockholder may authorize another person or persons to act for the stockholder as proxy by transmitting or authorizing the transmission of a telegram, cablegram, or other means of electronic transmission to the person who will
be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission if such telegram, cablegram or other means of
electronic transmission sets forth or is submitted with information from which it can be determined that the telegram, cablegram or other electronic transmission was authorized by the stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(2) </B>No proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(3) </B>A duly executed proxy shall be irrevocable if it states that it is irrevocable and if, and only so long as, it is coupled with an interest
sufficient in law to support an irrevocable power. A proxy may be made irrevocable regardless of whether the interest with which it is coupled is an interest in the stock itself or an interest in the corporation generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.08. </B><B><U>Voting Lists</U></B><B>. </B>A complete list of stockholders of the corporation entitled to vote at any meeting of stockholders of
the corporation, arranged in alphabetical order for each class of stock and showing the address of each such stockholder and the number of shares registered in the name of such stockholder, shall be open to the examination of any such stockholder,
for any purpose germane to a meeting of the stockholders of the corporation, for a period of at least 10 days before the meeting (i)&nbsp;on a reasonably accessible electronic network, provided that the information required to gain access to such
list is provided with the notice of the meeting or (ii)&nbsp;during ordinary business hours at the principal place of business of the corporation; provided, however, if the record date for determining the stockholders entitled to vote is less than
10 days before the meeting date, the list shall reflect the stockholders entitled to vote as of the 10th day before such meeting date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporation may look to this list as the sole evidence of the identity of the stockholders entitled to
vote at a meeting and the number of shares held by each stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 3.09. </B><B><U>Inspectors of Election</U></B><B>.</B> Prior to a meeting
of the stockholders of the Corporation, the Corporation shall appoint one or more inspectors to act at a meeting of stockholders of the Corporation and make a written report thereof. The corporation may designate one or more persons as alternate
inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the person presiding at the meeting may, and to the extent required by applicable law, shall, appoint one or more
inspectors to act at the meeting. Each inspector, before beginning the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her
ability. The inspectors may appoint or retain other persons or entities to assist the inspectors in the performance of the duties of inspectors. The inspectors shall have the duties prescribed by applicable law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BOARD OF
DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.01. </B><B><U>Powers</U></B><B>.</B> All powers vested by law in the corporation shall be exercised by or under the authority
of, and the business and affairs of the corporation shall be managed under the direction of, the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.02. </B><B><U>Number
and Term of Office</U></B><B>.</B> The board of directors shall consist of such number of directors, not less than 1, as may be determined from time to time by resolution of the board of directors. Each director shall hold office until the
expiration of the term for which he or she was selected and until a successor shall have been elected and qualified or until his or her earlier death, resignation or removal. Directors need not be residents of Delaware or stockholders of the
corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.03. </B><B><U>Vacancies</U></B><B>. </B>Vacancies and newly created directorships resulting from any increase in the authorized
number of directors elected by all of the stockholders having a right to vote as a single class may be filled by a majority of the directors then in office, though less than a quorum, or by a sole remaining director, and the directors so chosen
shall hold office until their successors are elected and qualified or until their earlier death, resignation or removal. If there are no directors in office, then an election of directors may be held in the manner provided by statute. Whenever the
holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the certificate of incorporation, vacancies and newly created directorships of such class or classes or series may be filled
by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected. If, at the time of filling any vacancy or any newly created directorship, the directors then in office
shall constitute less than a majority of the whole board (as constituted immediately prior to any such increase), the Court of Chancery may, upon application of any stockholder or stockholders holding at least ten percent of the total number of the
shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.04. </B><B><U>Resignations</U></B><B>. </B>Any director may resign at any time upon written notice to the corporation. The resignation shall be
effective upon receipt thereof by the corporation or at such subsequent time as shall be specified in the notice of resignation and, unless otherwise specified in the notice, the acceptance of the resignation shall not be necessary to make it
effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.05. </B><B><U>Removal</U></B><B>. </B>Any director or the entire board of directors may be removed, but only with cause, by the
holders of shares entitled to cast a majority of the votes which all stockholders are entitled to cast at an election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.06.
</B><B><U>Organization</U></B><B>. </B>At every meeting of the board of directors, the chairman of the board, if there be one, or, in the case of a vacancy in the office or absence of the chairman of the board, one of the following officers present
in the order stated: the vice chairman of the board, if there be one, the president, the vice presidents in their order of rank and seniority, or a chairman chosen by a majority of the directors present, shall preside, and the secretary, or, in the
absence of the secretary, an assistant secretary, or in the absence of the secretary and the assistant secretaries, any person appointed by the chairman of the meeting, shall act as secretary. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.07. </B><B><U>Place of Meeting</U></B><B>. </B>Meetings of the board of directors shall be held
at such place within or without the State of Delaware as the board of directors may from time to time determine, or as may be designated in the notice of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.08. </B><B><U>Regular Meetings</U></B><B>.</B> Regular meetings of the board of directors shall be held without notice at such time and place as
shall be designated from time to time by resolution of the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.09. </B><B><U>Special Meetings</U></B><B>. </B>Special
meetings of the board of directors shall be held whenever called by the president or by two or more of the directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.10. <U>Quorum, Manner
of Acting and Adjournment</U>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><U>General Rule</U></B><B>. </B>At all meetings of the board, a majority of the total number of directors
shall constitute a quorum for the transaction of business. If a quorum is not present at any meeting of the board of directors, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the
meeting, until a quorum is present. The vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the board of directors, except as may be otherwise specifically provided by the DGCL or by the
certificate of incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><U>Unanimous Written Consent</U></B><B>. </B>Unless otherwise restricted by the certificate of incorporation,
any action required or permitted to be taken at any meeting of the board of directors may be taken without a meeting, if all members of the board consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of
the board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.11. </B><B><U>Committees</U></B><B>. </B>The board of directors may designate committees of the board of directors, with such
lawfully delegable powers and duties as it thereby confers, to serve at the pleasure of the board of directors and shall, for those committees, appoint a director or directors to serve as the member or members, designating, if it desires, other
directors as alternate members who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of any member of any committee and any alternate member in his or her place, the member or members
of the committee present at the meeting and not disqualified from voting, whether or not he or she or they constitute a quorum, may by unanimous vote appoint another member of the board of directors to act at the meeting in the place of the absent
or disqualified member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 4.12. </B><B><U>Compensation of Directors</U></B><B>. </B>Unless otherwise restricted by the certificate of
incorporation, the board of directors shall have the authority to fix the compensation of directors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.01.
</B><B><U>Number, Qualifications and Designation</U></B><B>.</B> The officers of the corporation shall be chosen by the board of directors and shall be a president, one or more vice presidents, a secretary, a treasurer, a chief financial officer and
such other officers as may from time to time be appointed by the board or directors. Any number of offices may be held by the same person. Officers may, but need not, be directors or stockholders of the corporation. The board of directors may elect
from among the members of the board a chairman of the board and a vice chairman of the board who shall be officers of the corporation. Unless otherwise determined by the Board of Directors, the President shall be the Chief Executive Officer of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.02. </B><B><U>Subordinate Officers, Committees and Agents</U></B><B>. </B>The board of directors may from time to time elect
such other officers and appoint such committees, employees or other agents as it deems necessary, who shall hold their offices for such terms and shall exercise such powers and perform such duties as are provided in these bylaws, or as the board of
directors may from time to time determine. The board of directors may delegate to any officer or committee the power to elect subordinate officers and to retain or appoint employees or other agents, or committees thereof, and to prescribe the
authority and duties of such subordinate officers, committees, employees or other agents. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.03. </B><B><U>The Chairman and Vice Chairman of the Board</U></B><B>. </B>The chairman of the
board, if there be one, or in the absence of the chairman, the vice chairman of the board, if there be one, shall preside at all meetings of the stockholders and of the board of directors, and shall perform such other duties as may from time to time
be assigned to them by the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.04. </B><B><U>The President</U></B><B>. </B>The president shall have general supervision over
the business and operations of the corporation, subject, however, to the control of the board of directors. The president shall, in general, perform all duties incident to the office of president, and such other duties as from time to time may be
assigned by the board of directors and, if the chairman of the board is the chief executive officer, the chairman of the board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.05.
</B><B><U>The Vice Presidents</U></B><B>. </B>The vice presidents shall perform the duties of the president in the absence of the president and such other duties as may from time to time be assigned to them by the board of directors or by the
president. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.06. </B><B><U>The Secretary</U></B><B>. </B>The secretary, or an assistant secretary, shall attend all meetings of the
stockholders and of the board of directors and shall record the proceedings of the stockholders and of the directors and of committees of the board in a book or books to be kept for that purpose; shall see that notices are given and records and
reports properly kept and filed by the corporation as required by law; shall be the custodian of the seal of the corporation and see that it is affixed to all documents to be executed on behalf of the corporation under its seal; and, in general,
shall perform all duties incident to the office of secretary, and such other duties as may from time to time be assigned by the board of directors or the president. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.07. </B><B><U>The Chief Financial Officer</U></B><B>. </B>The chief financial officer shall keep or cause to be kept the books of account of the
corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the board or the president. The chief financial officer, subject to the order of the Board
of Directors, shall have the custody of all funds and securities of the corporation. The chief financial officer shall perform other duties commonly incident to his office and shall also perform such other duties and have such other powers as the
board or the president shall designate from time to time. The president may direct the treasurer or any assistant treasurer to assume and perform the duties of the chief financial officer in the absence or disability of the chief financial officer,
and each treasurer and assistant treasurer shall perform other duties commonly incident to his office and shall also perform such other duties and have such other powers as the board of directors or the president shall designate from time to time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.08. </B><B><U>Officers&#8217; Bonds</U></B><B>.</B> No officer of the corporation need provide a bond to guarantee the faithful discharge of
the officer&#8217;s duties unless the board of directors shall by resolution so require a bond in which event such officer shall give the corporation a bond (which shall be renewed if and as required) in such sum and with such surety or sureties as
shall be satisfactory to the board of directors for the faithful performance of the duties of office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.09. </B><B><U>Salaries</U></B><B>.</B>
The salaries of the officers and agents of the corporation elected by the board of directors shall be fixed from time to time by the board of directors or a committee thereof or by the officers as may be designated by resolution of the board of
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 5.10. </B><B><U>Removal</U></B>. The board of directors may remove any officer of the corporation at any time, with or without
cause. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATES OF STOCK, TRANSFER, ETC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.01. <U>Form and Issuance</U>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a)
</B><B><U>Issuance</U></B><B>. </B>The shares of the corporation shall be represented by certificates unless the board of directors shall by resolution provide that some or all of any class or series of stock shall be uncertificated shares. Any such
resolution shall not apply to shares represented by a certificate until the certificate is surrendered to the corporation. Notwithstanding the adoption of any resolution providing for uncertificated shares, every holder of stock represented by
certificates and upon request every holder of uncertificated shares shall be entitled to have a certificate signed by, or in the name of the corporation by, the chairman or vice chairman of the board of directors, or the president or vice president,
and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary, representing the number of shares registered in certificate form. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><U>Form and Records</U></B><B>. </B>Stock certificates of the corporation shall be in such
form as approved by the board of directors. The stock record books and the blank stock certificate books shall be kept by the secretary or by any agency designated by the board of directors for that purpose. The stock certificates of the corporation
shall be numbered and registered in the stock ledger and transfer books of the corporation as they are issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><U>Signatures</U></B><B>.
</B>Any of or all the signatures upon the stock certificates of the corporation may be a facsimile. In case any officer, transfer agent or registrar who has signed, or whose facsimile signature has been placed upon, any share certificate shall have
ceased to be such officer, transfer agent or registrar, before the certificate is issued, it may be issued with the same effect as if the signatory were such officer, transfer agent or registrar at the date of its issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.02. </B><B><U>Transfer</U></B><B>. </B>Transfers of shares shall be made on the share register or transfer books of the corporation upon
surrender of the certificate therefor, endorsed by the person named in the certificate or by an attorney lawfully constituted in writing. No transfer shall be made which would be inconsistent with the provisions of Article 8, Title 6 of the Delaware
Uniform Commercial Code-Investment Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.03. </B><B><U>Lost, Stolen, Destroyed or Mutilated Certificates</U></B><B>. </B>The board of
directors may direct a new certificate of stock or uncertificated shares to be issued in place of any certificate theretofore issued by the corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by
the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing such issue of a new certificate or certificates, the board of directors may, in its discretion and as a condition precedent to the issuance thereof,
require the owner of such lost, stolen or destroyed certificate or certificates, or the legal representative of the owner, to give the corporation a bond sufficient to indemnify against any claim that may be made against the corporation on account
of the alleged loss, theft or destruction of such certificate or the issuance of such new certificate or uncertificated shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.04.
</B><B><U>Record Holder of Shares</U></B><B>.</B> The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and to hold liable for
calls and assessments a person registered on its books as the owner of shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have
express or other notice thereof, except as otherwise provided by the laws of Delaware. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 6.05. <U>Determination of Stockholders of Record</U>.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><U>Meetings of Stockholders</U></B><B>. </B>In order that the corporation may determine the stockholders entitled to notice of or to
vote at any meeting of stockholders or any adjournment thereof, the board of directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the board of directors, and
which record date shall not be more than 60 nor less than ten days before the date of such meeting. If no record date is fixed by the board of directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of
stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting unless the board of directors fixes a new record date for the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B><U>Dividends</U></B><B>. </B>In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other
distribution or allotment of any rights of the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the board of directors may fix a record date, which
record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining stockholders
for any such purpose shall be at the close of business on the day on which the board of directors adopts the resolution relating thereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION OF DIRECTORS, OFFICERS AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER AUTHORIZED REPRESENTATIVES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.01. </B><B><U>Indemnification of Authorized Representatives in Third Party Proceedings</U></B><B>. </B>The corporation shall indemnify any person
who was or is an authorized representative of the corporation, and who was or is a party, or is threatened to be made a party to any third party proceeding, by reason of the fact that such person was or is an authorized representative of the
corporation, against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such third party proceeding if such person acted in good faith and in a manner such person reasonably
believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal third party proceeding, had no reasonable cause to believe such conduct was unlawful. The termination of any third party proceeding by
judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, shall not of itself create a presumption that the authorized representative did not act in good faith and in a manner which such person reasonably believed
to be in or not opposed to, the best interests of the corporation, and, with respect to any criminal third party proceeding, had reasonable cause to believe that such conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.02. </B><B><U>Indemnification of Authorized Representatives in Corporate Proceedings</U></B><B>. </B>The corporation shall indemnify any person
who was or is an authorized representative of the corporation and who was or is a party or is threatened to be made a party to any corporate proceeding, by reason of the fact that such person was or is an authorized representative of the
corporation, against expenses actually and reasonably incurred by such person in connection with the defense or settlement of such corporate proceeding if such person acted in good faith and in a manner reasonably believed to be in, or not opposed
to, the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that
the Court of Chancery or the court in which such corporate proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such authorized representative is fairly
and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.03.
</B><B><U>Mandatory Indemnification of Authorized Representatives</U></B><B>. </B>To the extent that an authorized representative or other employee or agent of the corporation has been successful on the merits or otherwise in defense of any third
party or corporate proceeding or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses actually and reasonably incurred by such person in connection therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.04. </B><B><U>Determination of Entitlement to Indemnification</U></B><B>. </B>Any indemnification under section 7.01, 7.02 or 7.03 of this
Article (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the authorized representative or other employee or agent is proper in the circumstances because
such person has either met the applicable standard of conduct set forth in section 7.01 or 7.02 or has been successful on the merits or otherwise as set forth in section 7.03 and that the amount requested has been actually and reasonably incurred.
Such determination shall be made: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) by the board of directors by a majority vote of a quorum consisting of directors who were not parties to such third
party or corporate proceeding; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) if such a quorum is not obtainable, or even if obtainable, a quorum of disinterested directors so directs, by
independent legal counsel in a written opinion; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) by the stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.05. </B><B><U>Advancing Expenses</U></B><B>. </B>Expenses actually and reasonably incurred in defending a third party or corporate proceeding
shall be paid on behalf of an authorized representative by the corporation in advance of the final disposition of such third party or corporate proceeding upon receipt of an undertaking by or on behalf of the authorized representative to repay such
amount if it shall ultimately be determined that the authorized representative is not entitled to be indemnified by the corporation as authorized in this Article. The financial ability of any authorized representative to make a repayment
contemplated by this section shall not be a prerequisite to the making of an advance. Expenses incurred by other employees and agents may be so paid upon such terms and conditions, if any, as the board of directors deems appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.06. </B><B><U>Definitions</U></B><B>. </B>For purposes of this Article: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(1) &#8220;authorized representative&#8221; shall mean any and all directors and officers of the corporation and any person designated as an authorized
representative by the board of directors of the corporation (which may, but need not, include any person serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(2) &#8220;corporation&#8221; shall include, in addition to the resulting corporation, any constituent
corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so that any
person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, shall stand in the same position under the provisions of this Article with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate
existence had continued; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(3) &#8220;corporate proceeding&#8221; shall mean any threatened, pending or completed action or suit by or in the right of the
corporation to procure a judgment in its favor or investigative proceeding by the corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) &#8220;criminal third party proceeding&#8221; shall
include any action or investigation which could or does lead to a criminal third party proceeding; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) &#8220;expenses&#8221; shall include
attorneys&#8217; fees and disbursements; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(6) &#8220;fines&#8221; shall include any excise taxes assessed on a person with respect to an employee benefit
plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(7) &#8220;not opposed to the best interests of the corporation&#8221; shall include actions taken in good faith and in a manner the authorized
representative reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(8) &#8220;other
enterprise&#8221; shall include employee benefit plans; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(9) &#8220;party&#8221; shall include the giving of testimony or similar involvement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(10) &#8220;serving at the request of the corporation&#8221; shall include any service as a director, officer or employee of the corporation which imposes
duties on, or involves services by, such director, officer or employee with respect to an employee benefit plan, its participants, or beneficiaries; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(11) &#8220;third party proceeding&#8221; shall mean any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative,
or investigative, other than an action by or in the right of the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.07. </B><B><U>Insurance</U></B><B>.</B> The corporation may
purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise against any liability asserted against the person and incurred by the person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power
or the obligation to indemnify such person against such liability under the provisions of this Article. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.08. </B><B><U>Scope of
Article</U></B><B>. </B>The indemnification of authorized representatives and advancement of expenses, as authorized by the preceding provisions of this Article, shall not be deemed exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled under any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in an official capacity and as to action in another capacity while holding such office.
The indemnification and advancement of expenses provided by or granted pursuant to this Article shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be an authorized representative and shall inure
to the benefit of the heirs, executors and administrators of such a person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 7.09. </B><B><U>Reliance on Provisions</U></B><B>. </B>Each person
who shall act as an authorized representative of the corporation shall be deemed to be doing so in reliance upon rights of indemnification provided by this Article. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL
PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.01. </B><B><U>Dividends</U></B><B>.</B> Subject to the restrictions contained in the DGCL and any restrictions contained in
the certificate of incorporation, the board of directors may declare and pay dividends upon the shares of capital stock of the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION
8.02. </B><B><U>Contracts</U></B><B>.</B> Except as otherwise provided in these bylaws, the board of directors may authorize any officer or officers including the chairman and vice chairman of the board of directors, or any agent or agents, to enter
into any contract or to execute or deliver any instrument on behalf of the corporation and such authority may be general or confined to specific instances. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.03. </B><B><U>Corporate Seal</U></B><B>. </B>The board of directors may adopt a corporate seal.
The seal may be used by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.04.
</B><B><U>Deposits</U></B><B>. </B>All funds of the corporation shall be deposited from time to time to the credit of the corporation in such banks, trust companies, or other depositories as the board of directors may approve or designate, and all
such funds shall be withdrawn only upon checks signed by such one or more officers or employees as the board of directors shall from time to time determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 8.05. </B><B><U>Amendment of Bylaws</U></B><B>. </B>These bylaws may be altered, amended or repealed in accordance with the certificate of
incorporation of the corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORUM SELECTION BYLAW </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.01.
</B>Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware and any appellate court therefrom shall be the sole and exclusive forum for: (A)&nbsp;any derivative claim or
cause of action brought on behalf of the Corporation; (B)&nbsp;any claim or cause of action that is based upon a violation of a duty owed by any current or former director, officer, other employee or stockholder of the Corporation, to the
Corporation or the Corporation&#8217;s stockholders; (C)&nbsp;any claim or cause of action against the Corporation or any current or former director, officer or other employee of the Corporation, arising out of or pursuant to any provision of the
DGCL, the certificate of incorporation or the bylaws; (D)&nbsp;any claim or cause of action seeking to interpret, apply, enforce or determine the validity of the certificate of incorporation or the bylaws (including any right, obligation, or remedy
thereunder); (E) any claim or cause of action as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; and (F)&nbsp;any claim or cause of action against the Corporation or any current or former director, officer
or other employee of the Corporation, governed by the internal-affairs doctrine or otherwise related to the Corporation&#8217;s internal affairs, in all cases to the fullest extent permitted by applicable law; provided, however, that if such court
does not have, or declines to accept, jurisdiction over such a claim or cause of action, then the United States District Court for the District of Delaware shall be the sole and exclusive forum for such claim or cause of action. Any person or entity
purchasing or otherwise acquiring or holding any interest in shares of capital stock of the corporation shall be deemed to have notice of and consented to the provisions of this Section&nbsp;9.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SECTION 9.02. </B>Unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent permitted by applicable law,
the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the 1933 Act, including all causes of action asserted against any defendant named
in such complaint. For the avoidance of doubt, this provision is intended to benefit and may be enforced by the Corporation, its officers and directors, the underwriters for any offering giving rise to such complaint, and any other professional
entity whose profession gives authority to a statement made by that person or entity and who has prepared or certified any part of the documents underlying the offering. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>nerv-20260603.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/4/2026 11:48:37 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:nerv="http://minervaneurosciences.com/20260603"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://minervaneurosciences.com/20260603"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nerv-20260603_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nerv-20260603_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>nerv-20260603_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/4/2026 11:48:37 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>nerv-20260603_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/4/2026 11:48:37 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="nerv-20260603.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 03, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001598646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  03,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Minerva Neurosciences, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-0784194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1500 District Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Burlington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">600-7373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NERV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d57321d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d57321d8k.htm">d57321d8k.htm</File>
    <File>nerv-20260603.xsd</File>
    <File>nerv-20260603_lab.xml</File>
    <File>nerv-20260603_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d57321d8k.htm": {
   "nsprefix": "nerv",
   "nsuri": "http://minervaneurosciences.com/20260603",
   "dts": {
    "inline": {
     "local": [
      "d57321d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "nerv-20260603.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "nerv-20260603_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nerv-20260603_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-06-03_to_2026-06-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d57321d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-06-03_to_2026-06-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d57321d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://minervaneurosciences.com//20260603/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-26-257379-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-257379-xbrl.zip
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MGHY)G6F=[>:XJDF4\:]C?BO*?2GX=XQ).[;H\CL?Q&%M+AFT3,OH@]6=:X*
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MZQGZL*2CR VY)_PH<"<L /L0#";TI'[ [P,C%-31APJ9<& $_4C5VG=A5'P
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M6IV;O(YC<%SM^_8$/H.7Z)[\/U!+ P04    " "IH,1<T$69 LT'  #,&P
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MA"*S1,E4!5.]Z3% 5L_8L2:9.Z<]@C?]$^P!3C-Q%W)M$#3[''F9L7G#"DB
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M1(>/.OP\SYJR0+Z>9]BRH1'A6FC0=U%?9^5!8G$!54Z%<*0'G8;(8 TG.=R
MC)&P$=&/B5-;;'7CT]Q3ST*GR"2PX)YY;K[A<@_Y#4@P[4QDCOFJ6+;27]$
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M8_DTOG4>O?=0Z8@!PX"AHS"-N;RD<.34!],PLE;0E^Q@P'AFM3'UZG'P4TJ
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M5Y-O0F$#+B%*;514TJ:WF]6^#KUT[AS7[(6C*3-A2\IXO\ <#U=B+U4I3(=
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M<_+ !7IW\B=\^//%+V]>_5]02P,$%     @ J:#$7"A]*H]N P  KPP  !$
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M#<NUD;I>\CLN]9;Y(ROI+IK\J1&]YS]02P,$%     @ J:#$7"4'M,K>!
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MZ_:O(7@0PQ&,![XM2W<NU7/Y#*1.*/^3+4[_:UH<P1&.>ZXMQ4MG*)KYI*.
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M'S>8IV W>\R;>:83M_P-4$L! A0#%     @ J:#$7#B8>Q"='0  S.(   T
M             ( !     &0U-S,R,60X:RYH=&U02P$"% ,4    " "IH,1<
MT$69 LT'  #,&P  #P              @ '('0  9#4W,S(Q9&5X,S$N:'1M
M4$L! A0#%     @ J:#$7"?Z&BN 3@  96X!  \              ( !PB4
M &0U-S,R,61E>#,R+FAT;5!+ 0(4 Q0    ( *F@Q%PH?2J/;@,  *\,   1
M              "  6]T  !N97)V+3(P,C8P-C S+GAS9%!+ 0(4 Q0    (
M *F@Q%P3X,=JE08  *E&   5              "  0QX  !N97)V+3(P,C8P
M-C S7VQA8BYX;6Q02P$"% ,4    " "IH,1<)0>TRMX$  !*+   %0
M        @ '4?@  ;F5R=BTR,#(V,#8P,U]P<F4N>&UL4$L%!@     &  8
*>@$  .6#      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d57321d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nerv-20260603.xsd" xlink:type="simple"/>
    <context id="duration_2026-06-03_to_2026-06-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001598646</identifier>
        </entity>
        <period>
            <startDate>2026-06-03</startDate>
            <endDate>2026-06-03</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2026-06-03_to_2026-06-03"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-628">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-06-03_to_2026-06-03"
      id="Hidden_dei_EntityCentralIndexKey">0001598646</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2026-06-03_to_2026-06-03"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2026-06-03_to_2026-06-03">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-640">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-641">2026-06-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-642">Minerva Neurosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-643">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-644">001-36517</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-645">26-0784194</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-646">1500 District Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-647">Burlington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-648">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-649">01803</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-650">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-651">600-7373</dei:LocalPhoneNumber>
    <dei:SolicitingMaterial contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-652">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-653">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-654">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-655">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-656">NERV</dei:TradingSymbol>
    <dei:WrittenCommunications contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-657">false</dei:WrittenCommunications>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-06-03_to_2026-06-03" id="ixv-658">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
